NCH2 is trading in a tighter range after last week's earnings, but the lending market tells a story that is anything but settled.
The ORTEX short score has continued climbing since the two notes published on August 12, reaching 96.2 on August 13 — the highest reading in the tracked history and up from 91.3 on August 3. The score has risen every single session over that stretch. Both the utilization rank and days-to-cover rank remain at the bottom percentile of the ORTEX universe. That relentless drift higher in the composite score reflects a borrow market that has not found any new equilibrium — it has been operating at near-maximum stress for the better part of six weeks.
The wrinkle this week is that cost to borrow has pulled back sharply, falling 38% on the week to 53.8% on August 13, from a chaotic run that included prints of 340% on July 31 and 189% on August 6. That drop is real, but the context matters: availability is still essentially exhausted at just 1.3% — roughly one share available for every 75 already lent out. The 52-week floor was 0.01%. Borrow rates oscillating between 50% and 340% on a near-daily basis is not normalization; it is the signature of a lending pool so thin that any modest shift in demand sends rates lurching. A CTB reading of 54% in this environment still represents severely elevated borrowing costs.
The Street offers a partial offset to the bearish positioning signal. The mean analyst price target is €10.52 against a current price of €7.91, implying roughly 33% upside from current levels. No recent analyst changes appear in the data. The earnings event on August 12 produced a modest 1-day decline of about 1.2% — the May print, by contrast, generated a 7.3% single-day gain. Factor scores paint a weak fundamental backdrop: EPS momentum ranks in the 11th percentile on a 30-day basis and the 2nd percentile on 90 days. The company remains loss-making, with negative PE and EV/EBITDA multiples. The price-to-book of 1.38x is the cleanest positive valuation signal available.
The ownership picture offers little in the way of near-term catalyst. ThyssenKrupp Projekt 1 GmbH and Federico De Nora hold a combined 76% of shares, and both positions were unchanged through the last reported period in September 2025. Saudi Arabia's Public Investment Fund holds 6%. The float available to trade is therefore narrow, which amplifies the lending dynamics already on display. Insider data is stale — the most recent trades on record date to February 2026 — so no fresh signal there.
Among correlated peers, AMRC added 8.8% on the week and MRB gained 8.6%, while NCH2 slipped 1.1% over the same period. That divergence is worth noting: the broader construction and infrastructure cohort caught a bid, but nucera's borrow constraints and post-earnings sentiment kept it on the back foot.
The next scheduled earnings event is December 16. Between now and then, the question is whether the borrow market finds any genuine relief — or whether cost-to-borrow volatility simply continues to oscillate at high levels while the short score grinds toward its ceiling.
See the live data behind this article on ORTEX.
Open NCH2 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
